|
|
North American Menopause Society and Others' Financial Ties to Wyeth Pharmaceuticals
Groups such as the North American Menopause Society and the American Medical Women’s Association are simultaneously promoting Wyeth products while denigrating alternatives to those products. And they're doing so without disclosing that they receive significant amounts of funding from Wyeth.
|
AACE Financial Ties to Wyeth
Although AACE supports Wyeth-backed policy from FDA that would restrict patient access to compounded hormones, they have failed to disclose that they receive significant funding from the pharmaceutical manufacturer.
|
AAEP and its Leadership Must Disclose Financial Relationships with Veterinary Drug Makers
Veterinary drug makers are waging a campaign to eliminate compounded medicines, which they perceive to be competition. And they are being aided and abetted by the American Association of Equine Practitioners, and it’s Drug Compounding Task Force.
|
The Truth Behind Wyeth’s Campaign Against BHRT Patients
Wyeth petitioned the FDA to impose far-reaching restrictions on compounded BHRT, but why?
|
Irresponsible Journalism: BusinessWeek Regurgitates Wyeth’s Attacks on Pharmacy Compounding
The article “Homegrown Hormone Therapy: How Safe?” published in the June 26 edition of BusinessWeek and written by Arlene Weintraub contains many inaccuracies, omissions and mischaracterizations that mislead its readers about the nature of pharmacy compounding...
|
Wyeth’s Campaign to Protect Market Share at the Expense of Women’s Health
Wyeth and its allies are conducting a campaign to restrict women’s access to bioidentical hormones – a treatment that many women in consultation with their physicians rely on to relieve the symptoms of hormone imbalance and menopause.
|
Wyeth's Previous Campaign to Stifle Generic Alternatives
In the 1990's, Wyeth conducted a campaign to keep a generic version to its decades-old Premarin off the market. Its campaign bears a striking resemblance to its current campaign to restrict patients' access to bioidentical hormones.
|
Pharmacy Compounding Subject to FDA Approval? The Facts Just Don't Fit
FDA says that compounding has been illegal ever since the Federal Food, Drug, and Cosmetic (FDC) Act was passed in 1938. The compounding profession disagrees, and the facts concur.
|
Landmark Ruling for Pharmacy Compounding in U.S. District Court
A federal judge rules that compounded preparations are not unapproved, new drugs subject to the FDA's new drug approval process.
|
FDA Issues Warning Letters to Pharmacies
In warning letters issued this month to three pharmacies, the Food and Drug Administration (FDA) makes several misinformed statements.
|
Internal FDA Memorandum Contradicts Public Statements
FDA contends that it has always held that compounded meds are “new, unapproved drugs” subject to the same requirements as manufactured products under the Food, Drug, and Cosmetic Act of 1938. A memo uncovered during a federal trial shows that the opposite is true...
|
Heard on the Street...Statements in Support of Compounding Pharmacy Practice
From the U.S. Supreme Court, to the Government Accounting Office, it seems like everyone has something positive to say about the value of compounding pharmacy.
|
How AstraZeneca is Mischaracterizing Pharmacy Compounding
AstraZeneca suggests that compounding is unsafe in Drug Topics
|
Flaws in AstraZeneca-backed CHASM’s FDA Filing
Learn the truth about CHASM’s false charges
|
What’s Wrong with AAEP’s Discriminatory Conference Policy
AAEP treats non-binding FDA CPGs as law
|
|
 |
bz29.JPG)
